What is Encorafenib: Uses, Dosage, Side Effects and More

Encorafenib is a targeted cancer medication that blocks specific proteins that help cancer cells grow and spread. It belongs to a class of drugs called BRAF inhibitors, which means it works by targeting a particular genetic mutation found in certain cancers. This medication is typically used as part of combination therapy, meaning it's given along with other cancer drugs to make treatment more effective.

What is Encorafenib?

Encorafenib is an oral cancer medication that specifically targets cancer cells with a BRAF V600E mutation. Think of it as a targeted missile that seeks out and blocks the faulty signals that tell cancer cells to multiply rapidly. Unlike chemotherapy that affects all fast-growing cells in your body, encorafenib is designed to be more precise in its approach.

The medication comes in capsule form and is taken by mouth, making it more convenient than many other cancer treatments that require hospital visits. It's what doctors call a "precision medicine" because it only works for cancers that have this specific genetic change.

What is Encorafenib Used For?

Encorafenib is primarily used to treat two types of cancer that have the BRAF V600E mutation. Your doctor will test your cancer cells to confirm this mutation is present before prescribing this medication.

The two main conditions it treats are metastatic melanoma and metastatic colorectal cancer. For melanoma, it's used when the cancer has spread to other parts of your body and cannot be removed by surgery. In colorectal cancer, it's typically reserved for cases where other treatments haven't worked effectively.

It's important to understand that encorafenib only works for cancers with this specific genetic mutation. About half of all melanomas and a smaller percentage of colorectal cancers have this mutation, which is why genetic testing is so crucial before starting treatment.

How Does Encorafenib Work?

Encorafenib works by blocking a protein called BRAF that sends growth signals to cancer cells. When this protein is mutated, it constantly tells cancer cells to grow and divide, even when they shouldn't. By blocking this faulty signal, encorafenib can slow down or stop cancer growth.

This medication is considered a moderately strong cancer drug, but it's generally better tolerated than traditional chemotherapy. It specifically targets the cancer cells while leaving most healthy cells alone, which typically results in fewer severe side effects.

The drug works best when combined with other targeted medications. For melanoma, it's often paired with binimetinib, another targeted drug that blocks a different growth pathway. This combination approach helps prevent the cancer from finding workarounds to continue growing.

How Should I Take Encorafenib?

Encorafenib should be taken exactly as your doctor prescribes, typically once daily at the same time each day. The capsules should be swallowed whole with a full glass of water and should not be opened, crushed, or chewed.

You can take this medication with or without food, but try to be consistent with your choice. If you choose to take it with food, a light meal or snack is usually sufficient. Some people find that taking it with food helps reduce stomach upset.

It's best to establish a routine by taking your medication at the same time each day. Many people find it helpful to set a daily alarm or use a pill organizer to stay on track. If you're taking it with other medications, space them out by at least two hours unless your doctor advises otherwise.

How Long Should I Take Encorafenib For?

The length of treatment with encorafenib varies greatly from person to person and depends on how well the cancer responds to treatment. Some people may take it for several months, while others may need it for years or until the cancer progresses.

Your doctor will monitor your response through regular scans and blood tests, typically every 6-12 weeks initially. These tests help determine whether the medication is working effectively and whether you should continue treatment.

Treatment usually continues as long as the cancer remains stable or is shrinking and you're tolerating the medication well. If serious side effects develop or the cancer starts growing again, your doctor may adjust the dose or switch to a different treatment approach.

What Are the Side Effects of Encorafenib?

Like all cancer medications, encorafenib can cause side effects, though not everyone experiences them. Most side effects are manageable with proper medical care and monitoring.

Common side effects that many people experience include fatigue, nausea, diarrhea, and muscle or joint pain. These symptoms are usually mild to moderate and often improve as your body adjusts to the medication over the first few weeks of treatment.

Here are the most frequently reported side effects you might notice:

• Fatigue and weakness
• Nausea and vomiting
• Diarrhea
• Muscle and joint pain
• Headache
• Fever
• Skin rash
• Hair loss or thinning

These common side effects are generally manageable with supportive care and rarely require stopping the medication entirely.

More serious side effects can occur, though they're less common. These require immediate medical attention and may include heart problems, severe skin reactions, or eye problems. Your doctor will monitor you closely for these more serious concerns through regular check-ups and tests.

Some rare but serious side effects to watch for include:

• Heart rhythm problems or chest pain
• Severe skin reactions or widespread rash
• Eye problems like blurred vision or eye pain
• Signs of liver problems like yellowing of skin or eyes
• Severe dehydration from persistent vomiting or diarrhea

If you experience any of these serious symptoms, contact your healthcare team immediately. They can provide guidance on managing side effects and may adjust your treatment plan if needed.

Who Should Not Take Encorafenib?

Encorafenib isn't suitable for everyone, and certain medical conditions or situations may make it unsafe for you to take this medication. Your doctor will carefully review your medical history before prescribing it.

You should not take encorafenib if you're allergic to the medication or any of its ingredients. Additionally, this medication can cause serious heart problems, so people with certain heart conditions may not be good candidates for treatment.

People who should avoid or use extreme caution with encorafenib include those with:

• Severe heart problems or heart rhythm disorders
• Severe liver disease
• Pregnant or breastfeeding women
• People planning to become pregnant
• Those with certain eye conditions
• People with a history of severe skin reactions to medications

Women of childbearing age need to use effective birth control during treatment and for several months after stopping the medication. Men should also use contraception during treatment as the drug can affect sperm and potentially harm a developing baby.

Encorafenib Brand Names

Encorafenib is available under the brand name Braftovi in most countries, including the United States. This is the most commonly prescribed form of the medication and is manufactured by Pfizer.

Some countries may have different brand names or generic versions available, but the active ingredient remains the same. Always make sure you're getting your medication from a reputable pharmacy and that it matches what your doctor prescribed.

Encorafenib Alternatives

Several other medications work similarly to encorafenib for treating BRAF-mutated cancers. The choice between these options depends on your specific type of cancer, overall health, and how well you tolerate different medications.

Other BRAF inhibitors include vemurafenib (Zelboraf) and dabrafenib (Tafinlar). These medications work through the same mechanism but may have slightly different side effect profiles or dosing schedules.

For some people, immunotherapy drugs like pembrolizumab (Keytruda) or nivolumab (Opdivo) might be considered as alternatives. These work differently by helping your immune system fight the cancer, rather than blocking specific proteins.

Your oncologist will consider factors like your cancer's specific characteristics, your overall health, and your personal preferences when recommending the best treatment approach for your situation.

Is Encorafenib Better Than Vemurafenib?

Both encorafenib and vemurafenib are effective BRAF inhibitors, but they have some important differences that might make one more suitable for you than the other. Clinical studies suggest that encorafenib may offer some advantages in terms of effectiveness and tolerability.

Encorafenib appears to have a longer half-life, meaning it stays in your system longer and may provide more consistent cancer control. Some studies have shown that people taking encorafenib may live longer without their cancer progressing compared to those taking vemurafenib.

In terms of side effects, encorafenib may cause fewer skin problems and joint pain compared to vemurafenib. However, both medications can cause similar side effects like fatigue, nausea, and diarrhea.

The choice between these medications often comes down to your individual circumstances, including your specific cancer type, other health conditions, and how well you tolerate each medication. Your oncologist will help you weigh the benefits and risks of each option.